FDAnews Announces — FDA: When it Comes to 3D Printing, the Future is Already Here Webinar, Sponsored by Dassault Systemes, Sept. 28, 2017

Share Article

3D Printing, Simulation and Digital Twin are at the forefront of the Precision Medicine Revolution. Using these technologies, Life Sciences companies are accelerating the delivery of next generation products that are personalized, more precise and higher quality than ever before, resulting in improved patient outcomes.

http://info.fdanews.com/fda-when-it-comes-to-3d-printing

According to the FDA, when it comes to 3D printing, the future is already here. Due to its versatility, the agency is evaluating the application of 3D printing in devices, drugs and biologics.

3D Printing, Simulation and Digital Twin are at the forefront of the Precision Medicine Revolution. Using these technologies, Life Sciences companies are accelerating the delivery of next generation products that are personalized, more precise and higher quality than ever before, resulting in improved patient outcomes.

Hear directly from Biomodex, an innovative MedTech company, about how they are pioneering 3D Printing, Simulation and Digital Twin technologies to assist surgeons in planning and preparation for complex interventional procedures with the use of 3D printed replicas of the patient’s anatomy.

Get the physician’s perspective from Dr. Jenny Chen, a trained neuroradiologist and founder/CEO of 3DHEALS. Dr. Chen will share her perspectives on fostering a collaborative and innovative 3D printing ecosystem within the global healthcare arena.

In addition, Stavros Stefanis, leader in Deloitte’s Product Development practice, will share insights on the use of 3D printing across different phases of the product development lifecycle. He will also discuss strategies to successfully integrate 3D printing into product development and manufacturing.

By bridging the gap between the digital and the physical environments innovative companies are accelerating the delivery of higher quality device and therapeutic healthcare solutions.

In this webinar, moderated by Axendia’s Daniel Matlis, attendees will learn:

  • FDA’s expectations and guidance on these technologies
  • How simulation and 3D models of human cells and organs could be bio-printed to accelerate clinical trials to support the Precision Medicine revolution
  • How 3D Printing can enhance quality, innovation and improve patient outcomes
  • How 3D Printing can result in shorter lead-times and better user (patient or physician) experience
  • How to leverage these technologies to deliver smart and connected personalized products
  • How 3D printing enables and creates market differentiation and opens non-traditional business areas

Webinar Details:
FDA: When it Comes to 3D Printing, the Future is Already Here
Are You Ready for the Precision Medicine Revolution?
Sponsored by Dassault Systemes
**FDAnews Free Webinar**
Sept. 28, 2017 — 1:30 p.m. – 2:30 p.m. ET
http://info.fdanews.com/fda-when-it-comes-to-3d-printing

Easy Ways to Register:
Online: http://info.fdanews.com/fda-when-it-comes-to-3d-printing    
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website